Advanced search
Publication Cover
Clinical Ophthalmology Volume 17, 2023 - Issue
Submit an article Journal homepage
267
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence

Debdulal Chakraborty1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9693-7882
ORCID Icon,
Soumen Mondal1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
,
Subhendu Boral1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
,
Arnab Das1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
,
Tushar Kanti Sinha1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
,
Saptorshi Majumdar1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
,
Ranabir Bhattacharya2 Department of MIS, Disha Eye Hospitals, Kolkata, West Bengal, India
&
Ritobroto Maitra3 Radical Health Tech, New Delhi, IndiaORCID Iconhttps://orcid.org/0000-0002-3409-6114
ORCID Icon show all
Pages 1067-1076 | Received 17 Feb 2023, Accepted 28 Mar 2023, Published online: 08 Apr 2023

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Eleftherios Chatzimichail, Kristina Pfau, Zisis Gatzioufas & Georgios D Panos. (2024) Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?. Drug Design, Development and Therapy 18, pages 365-374.
Read now
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Anat Loewenstein, Francesco Bandello & Baruch D Kuppermann. (2023) Preparing for the next decade of anti-VEGF biosimilars for retinal diseases: a focus on South Asia. Expert Opinion on Biological Therapy 23:8, pages 689-692.
Read now

Articles from other publishers (3)

Asim K. Ghosh, Usha S. Nikumbh, Chaitanya K. Shukla, Rohit S. Laul, Abhishek Dixit, Santosh K. Mahapatra, Sameera Nayak, Urmil M. Shah, Sandeep Parwal, Narendran Venkatapathy, Natasha Radhakrishnan, Anup Kelgaonkar, Sandeep Saxena, Divyansh Mishra, Vivek Pravin Dave, Perwez Khan, Manojkumar R. Saswade, Malli S. Shantilal, Kim Ramasamy, Smitha Sreekanta, Mandodari Rajurkar, Maulik Doshi, Sapan Behera, Piyush Patel, Shilpi Dhawan & Lalit Lakhwani. (2024) Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study. Ophthalmology and Therapy.
Crossref
Christos Papaioannou. (2024) Advancements in the treatment of age-related macular degeneration: a comprehensive review. Postgraduate Medical Journal.
Crossref
. (2023) Ranibizumab. Reactions Weekly 1971:1, pages 230-230.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.